Yatai Group: Subsidiary Plans to Publicly List and Transfer 5 Million Shares of Jiangsu Weikai'er, with a listing reserve price of no less than 191 million yuan

MetaMuskRat · 2026-03-21T02:35:00+00:00

Renmin Finance News March 19 – Yatai Group (600881) announced on March 19 that its wholly-owned subsidiary Yatai Pharmaceutical Group Co., Ltd. plans to publicly transfer 5 million shares of Jiangsu Weikael Pharmaceutical Technology Co., Ltd. (referred to as "Jiangsu Weikael") it holds through the Changchun Public Resource Trading Center, with a minimum listing price of not less than 191 million yuan.

MetaMuskRat

2026-03-21 02:35:00

People’s Financial News, March 19 — Yatai Group (600881) announced on March 19 that its wholly owned subsidiary, Yatai Pharmaceutical Group Co., Ltd., plans to publicly list and transfer 5 million shares of Jiangsu Weikai’er Pharmaceutical Technology Co., Ltd. (referred to as “Jiangsu Weikai’er”) at the Changchun Public Resources Exchange Center, with a minimum listing price of no less than 191 million yuan.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes